Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coartem versus Co-arinate for uncomplicated malaria in Rwanda
ISRCTN91805477Phase 4Completed
- Sponsor
- InterAct Therapeutics
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in malaria comparing Coartem with Co-arinate (2 arms). Primary endpoint: Parasitological and clinical response at day 42. Started Sep 2010; status: completed.
02
Drugs
lumefantrineartesunate + sulfamethoxypyrazine + pyrimethamine
03
Conditions
malaria
Beyond the preview
Go deeper on ISRCTN91805477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN91805477.